IP Library Granted Patent US 8,278,419
Granted Patent B2
US 8,278,419 · App. 12/606,382 · Granted Oct 2, 2012

Fibronectin type III domain based scaffold compositions, methods and uses

Assignee: Centocor Ortho Biotech Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,278,419
App. No.
12/606,382
Granted
Oct 2, 2012
Kind
B2
Abstract

A protein scaffold based on a consensus sequence of fibronectin type III (FN3) proteins, such as the tenth FN3 repeat from human fibronectin (human Tenascin), including isolated nucleic acids that encode a protein scaffold, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. In particular, protein scaffold molecules binding to IgG have been identified as useful for diagnostic and/or therapeutic applications.

Claims (1)

1. An isolated protein scaffold, comprising the amino acid sequence of SEQ ID NO:16.

Assignments (1)
CHANGE OF NAME Recorded Sep 24, 2015
From: CENTOCOR ORTHO BIOTECH INC.
To: JANSSEN BIOTECH, INC.
Reel/Frame 036675/0867 →
Continuity (2)
Provisional Application 61110120 · Oct 31, 2008
Related Publication 20100216708A1 · Aug 26, 2010